Continuing singleagent capecitabin as maintenance therapy after induction of XELOX (or FOLFOX) in firstline treatment of metastatic colorectal cancer

Category Primary study
JournalJournal of Clinical Oncology
Year 2015
This article has no abstract
Epistemonikos ID: 760a0124a3d35887e4e19ab3572a78d322c2bf10
First added on: Feb 07, 2025